Patent · US Active

Benzamides and related inhibitors of factor XA

US8518977B2 · kind B2 · utility

2Cited by

25References

3Claims

0Family size

Assignee

Millennium Pharmaceuticals, Inc. · US

Inventors

Bing-Yan Zhu · South San Francisco, US
Penglie Zhang · Foster City, US
Lingyan Wang · East Brunswick Township, US
Wenrong Huang · Cupertino, US
Erick Goldman · Concord, US
Wenhao Li · South San Francisco, US
Jingmei Zuckett · Bellevue, US
Yonghong Song · Foster City, US
Robert M. Scarborough · Belmont, US

Key dates

Filing date	Sep 28, 2011
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Sep 28, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.